(Z)-Endoxifen and Early Recurrence of Breast Cancer: An Explorative Analysis in a Prospective Brazilian Study

Adherence to treatment and use of co-medication, but also molecular factors such as CYP2D6 genotype, affect tamoxifen metabolism, with consequences for early breast cancer prognosis. In a prospective study of 149 tamoxifen-treated early-stage breast cancer patients from Brazil followed up for 5 year...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Thais Almeida, Werner Schroth, Jeanine Nardin, Thomas E. Mürdter, Stefan Winter, Solane Picolotto, Reiner Hoppe, Jenifer Kogin, Elisa Gaio, Angela Dasenbrock, Raquel Cristina Skrsypcsak, Lucia de Noronha, Matthias Schwab, Hiltrud Brauch, José Claudio Casali-da-Rocha
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-03-01
Colecção:Journal of Personalized Medicine
Assuntos:
breast cancer
CYP2D6
tamoxifen
(Z)-endoxifen
early recurrence
survival
Acesso em linha:https://www.mdpi.com/2075-4426/12/4/511
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados